Home LiteratureArticle Details
PMID: 11889230 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Regional and progressive thinning of the cortical ribbon in Huntington's disease.

Neurology ·Vol. 58 ·No. 5 ·2002-03-12 ·Pages 695-701

Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B

Abstract

Huntington's disease (HD) is a fatal and progressive neurodegenerative disease that is accompanied by involuntary movements, cognitive dysfunction, and psychiatric symptoms. Although progressive striatal degeneration is known to occur, little is known about how the disease affects the cortex, including which cortical regions are affected, how degeneration proceeds, and the relationship of the cortical degeneration to clinical symptoms. The cortex has been difficult to study in neurodegenerative diseases primarily because of its complex folding patterns and regional variability; however, an understanding of how the cortex is affected by the disease may provide important new insights into it. Novel automated surface reconstruction and high-resolution MR images of 11 patients with HD and 13 age-matched subjects were used to obtain cortical thickness measurements. The same analyses were performed on two postmortem brains to validate these methods. Regionally specific heterogeneous thinning of the cortical ribbon was found in subjects with HD. Thinning occurred early, differed among patients in different clinical stages of disease, and appeared to proceed from posterior to anterior cortical regions with disease progression. The sensorimotor region was statistically most affected. Measurements performed on MR images of autopsy brains analyzed similarly were within 0.25 mm of those obtained using traditional neuropathologic methods and were statistically indistinguishable. The authors propose that the cortex degenerates early in disease and that regionally selective cortical degeneration may explain the heterogeneity of clinical expression in HD. These measures might provide a sensitive prospective surrogate marker for clinical trials of neuroprotective medications.

MeSH Terms
Adult Cerebral Cortex/pathology Female Humans Huntington Disease/pathology,physiopathology Magnetic Resonance Imaging/methods Male Middle Aged
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Rosas H D
Department of Neurology, Massachusetts General Hospital and Harvard Medical School, 02129-4404, USA. rosas@helix.mgh.harvard.edu
Liu A K
Hersch S
Glessner M
Ferrante R J
Salat D H
van der Kouwe A
Jenkins B G
Dale A M
Fischl B
Article Info
Journal
Neurology
Abbr.
Neurology
ISSN
0028-3878
Published
2002-03-12
Pages
695-701
Language
English
Region
United States
NLM ID
0401060
Subset
IM
Grants
NIA NIH HHS · AG05886 · United States
NCCIH NIH HHS · AT00613 · United States
NINDS NIH HHS · NS02060 · United States
NINDS NIH HHS · NS35255 · United States
NINDS NIH HHS · NS37102 · United States
NINDS NIH HHS · NS39581 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com